Rodrigo Gularte-Merida

15PUBLICATIONS
112CO-AUTHORS
Predictive and prognostic markersChemotherapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 01, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated Liposarcoma.

Evan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar

|Sep 11, 2023
Therapy-Induced Senescence Contributes to the Efficacy of Abemaciclib in Patients with Dedifferentiated Liposarcoma.

Caroline E Gleason, Mark A Dickson, Mary E Klein Dooley

|Jun 15, 2022
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.

Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith

|Mar 02, 2022
Same-Cell Co-Occurrence of RAS Hotspot and BRAF V600E Mutations in Treatment-Naive Colorectal Cancer.

Rodrigo Gularte-Mérida, Shaleigh Smith, Anita S Bowman

|Oct 20, 2021
A High-Content Screen for C/EBPα Expression Identifies Novel Therapeutic Agents in Dedifferentiated Liposarcoma.

Christina V Angeles, Ana Velez, Jordan Rios

|Feb 02, 2021
Genetic characterisation of adult primary pleomorphic uterine rhabdomyosarcoma and comparison with uterine carcinosarcoma.

Charles W Ashley, Arnaud Da Cruz Paula, Lorenzo Ferrando

Pageof 3

Frequent Collaborators

7 joint publications

Jorge S Reis-Filho

3 joint publications

Anqi Li

3 joint publications

Sandra P D'Angelo

3 joint publications

Cristina R Antonescu